Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSolana Company

Solana Company

Financial Services Asset Management
PortfolioPortfolio WatchlistWatchlist
Company price
1.935 USD 0.01 ( 0.26%)
Last update at 2026-11-06T21:00:00Z
VOLUME
580214
Market Cap
133.61M
P/E
0.01

Momentum Score

…

Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.90
Low
1.96
High
52 Week Price Range
1.19
Low
25.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Helius Medical Technologies develops non‑invasive neuromodulation devices aimed at improving gait and balance after traumatic brain injury and other neurological conditions. Growth drivers include expanding clinical evidence, progress on regulatory and reimbursement pathways, and broader commercial rollout; investors may view the company as exposed to a niche with limited drug alternatives and potential for increasing device adoption.
Key risks are regulatory and reimbursement uncertainty, limited commercial traction to date creating financing needs, and competitive and execution risks scaling a novel medical device.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.93
Dividend Yield
-
Revenue TTM
12.07M
Revenue Per Share
0.20
Gross Profit TTM
11.53M
Debt / Equity
0.01
ROE
-179.01%
Net Debt
-7.28M
ROCE
-13.38%
Diluted EPS TTM
189.90

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -40.89M -11.74M -8.85M -14.07M -18.13M
Net income -40.89M -11.74M -8.85M -12.56M -18.12M
Selling general administrative 23.13M 9.47M 9.61M 10.64M 12.18M
Selling and marketing expenses - 0.65M - - -
Gross profit 5.52M -0.06M 0.06M 0.32M 0.22M
Reconciled depreciation - 0.06M 0.18M 0.26M 0.20M
Ebit -40.26M -13.86M -12.27M -14.76M -18.14M
Ebitda -39.58M -13.80M -12.11M -16.09M -17.95M
Depreciation and amortization 0.68M 0.06M 0.16M -1.33M 0.19M
Operating income -21.12M -13.90M -12.43M -14.76M -18.14M
Other operating expenses 27.14M 14.42M 13.07M 15.55M 18.66M
Interest expense 0.64M 0.02M 0.26M 0.83M 0.01M
Tax provision 0.00M 0.00M 0.00M 0.00M -
Net interest income -195.82M -0.02M 0.34M -0.83M -
Income tax expense - - -0.01M -1.51M -0.01M
Total revenue 6.02M 0.52M 0.64M 0.79M 0.52M
Total operating expenses 26.64M 13.84M 12.49M 15.08M 18.37M
Cost of revenue 0.50M 0.58M 0.58M 0.46M 0.30M
Total other income expense net -19.77M 2.16M 3.58M 0.69M 0.01M
Net income from continuing ops -40.89M -11.74M -12.69M -14.07M -18.13M
Net income applicable to common shares - - - -14.07M -18.13M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 303.93M 3.54M 7.69M 17.29M 14.10M
Intangible assets 196.72M - 0.02M 0.14M 0.33M
Other current assets 22.75M 0.61M 1.02M 1.22M 0.86M
Total liab 3.02M 2.48M 5.34M 9.14M 2.85M
Total stockholder equity 300.91M 1.06M 2.35M 8.15M 11.26M
Other current liab 1.13M 1.24M 1.26M 1.28M 1.43M
Common stock 0.04M 0.00M 0.00M 0.03M 0.00M
Capital stock 0.04M 0.00M 0.00M 0.03M 0.00M
Retained earnings -212.59M -171.70M -159.96M -151.11M -137.03M
Other liab - - - 7.09M 0.19M
Good will - - - 0.00M 0.76M
Cash 7.28M 1.09M 5.18M 14.55M 11.01M
Total current liabilities 3.02M 2.16M 1.88M 1.99M 2.65M
Current deferred revenue - 0.04M 0.04M 0.03M 0.15M
Net debt -7.28M -1.08M -5.12M -14.44M -11.00M
Short term debt - 0.01M 0.04M 0.05M 0.00M
Short long term debt total - 0.01M 0.06M 0.11M 0.00M
Other stockholder equity 513.72M 172.42M 162.98M 159.62M 149.41M
Property plant equipment - - - 0.45M 0.41M
Total current assets 31.16M 3.42M 7.30M 16.70M 12.59M
Long term investments 5.62M 0.00M - - -
Net tangible assets - - - 8.01M 10.16M
Net receivables - 0.64M 0.64M 0.34M 0.25M
Inventory 1.12M 1.09M 0.46M 0.59M 0.48M
Accounts payable 1.89M 0.87M 0.53M 0.63M 1.07M
Accumulated other comprehensive income -0.26M 0.33M -0.67M -0.39M -1.12M
Non currrent assets other 0.07M 0.01M 0.14M - -
Non current assets total 272.77M 0.12M 0.39M 0.59M 1.51M
Capital lease obligations - 0.01M 0.06M 0.11M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -428.98M -0.01M -0.02M -0.01M -0.06M
Change to liabilities - - - -0.54M 0.21M
Total cashflows from investing activities -426.53M -0.01M -0.03M -0.01M -0.06M
Net borrowings -0.68M 0.00M - - -
Total cash from financing activities 449.24M 6.95M 1.08M 17.87M 21.13M
Change to operating activities - - - -0.64M -0.03M
Net income -40.89M -11.74M -8.85M -14.07M -18.13M
Change in cash 6.19M -4.09M -9.37M 3.54M 7.67M
Begin period cash flow 1.09M 5.18M 14.55M 11.01M 3.33M
End period cash flow 7.28M 1.09M 5.18M 14.55M 11.01M
Total cash from operating activities -16.51M -11.04M -10.42M -14.31M -13.39M
Issuance of capital stock 29.90M 2.96M 0.28M 18.64M 22.70M
Depreciation 0.68M 0.06M 0.16M 0.26M 0.31M
Other cashflows from investing activities -426.53M - - - -
Change to inventory -0.09M -0.61M 0.14M -0.11M -0.09M
Change to account receivables - -0.01M -0.29M -0.01M 0.03M
Other cashflows from financing activities -17.11M 3.99M 0.58M -0.78M -1.57M
Change to netincome - - - 0.81M 4.30M
Capital expenditures 44.78M 0.01M 0.03M 0.02M 0.06M
Change in working capital 0.23M -0.01M -0.31M -1.31M 0.13M
Stock based compensation 9.25M 2.52M 1.63M 2.25M 4.25M
Other non cash items 14.22M -1.87M -3.05M -1.44M 0.08M
Free cash flow -61.29M -11.05M -10.45M -14.33M -13.44M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HSDT
Solana Company		 0.01
0.26%		 1.94 0.01 - 11.07 0.82 11.48 -0.01
BLK
BlackRock Inc		 -
-%		 1178.87 26.25 19.57 6.33 2.90 6.35 17.13
BX
Blackstone Group Inc		 -0.32
0.27%		 119.50 33.20 20.12 11.05 11.56 9.14 15.74
IVSBF
Investor AB ser. B		 -1.77
4.00%		 42.50 4.67 3.83 3.78 1.13 4.15 1.68
KKR
KKR & Co. Inc.		 -1.82
1.85%		 96.48 32.68 13.66 3.58 3.22 0.68 1.47

Profile*

Solana Company

Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.

642 Newtown Yardley Road, Newtown, PA, United States, 18940

215 944 6100

https://www.solanacompany.co

21

Name Title Year Born
Mr. Dane Carl Andreeff Pres, CEO & Director 1966
Mr. Jeffrey S. Mathiesen CPA, CPA CFO, Treasurer, Sec. & Director 1961
Dr. Antonella Favit-Van Pelt M.D., Ph.D. Chief Medical Officer 1967
Mr. Lawrence Picciano Sr. VP of Engineering, Quality & Regulatory Affairs NA
Dr. Brian W. Bapty Ph.D. VP of Strategy and Bus. Devel. 1969
Mr. Dane Carl Andreeff President, CEO & Director 1966
Mr. Jeffrey S. Mathiesen CPA CFO, Treasurer, Secretary & Director 1961
Dr. Antonella Favit-Van Pelt M.D., Ph.D. Chief Medical Officer 1968
Mr. Lawrence Picciano Senior Vice President of Engineering, Quality & Regulatory Affairs NA
Mr. Choon Wee Chee CEO, President & Chairman 1972

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…